Skip to main content

2023 PharmSci 360 Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Ibtihal Abdulla, Pharm.D.

Hamad General Hospital, Qatar

Poster(s):

(M1230-10-67) Rivaroxaban Pharmacokinetics after Single Oral Dose in Obese Subjects: An Open-Label Controlled Clinical Trial

Monday, October 23, 2023
12:30 PM – 1:30 PM ET